April 17, 2015
Patient financial burdens addressed in new bill
The AADA took to Capitol Hill this week to advocate for passage of the Patients’ Access to Treatment Act (PATA) – a bill to alleviate patient expenses for specialty tier medications. In a letter to the bill’s co-sponsors, the AADA praises the legislation as an essential first-step to improve access to life-saving, life-improving medications.
Alarmingly, studies show average annual out-of-pocket therapy costs for psoriasis can reach $26,000. A number of reports indicate that patients are foregoing and delaying effective treatments as a result of high out-of-pocket costs. As a top advocacy priority, the AADA plans to continue advocating for passage of PATA and other laws to improve patient access to medications.
- AADA grassroots advocacy helps pass historic SGR, global codes bill
- Requirements for biosimilar substitution key to protecting patient safety
- AADA responds to FDA review of sunscreen ingredients
- UHC suspends lab accreditation, secondary read requirements in Florida